PAMORELIN
Dead / Cancelled — Cancelled — Section 8 (as of 23 May 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87568745
- Registration number
- 5604338
- Mark type
- Stylized text
- Filed
- 15 Aug 2017
- Published for opposition
- 28 Aug 2018
- Registered
- 13 Nov 2018
- Attorney of record
- Duane M. Byers
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, chemiotherapeutical medicines and medicines that act on the endocrinal functions, hormones, and on metabolism for the treatment of prostate cancer, endometriosis, precocious puberty, breast cancer, in vitro fertilization, ovarian cancer, fibroma and polycystic ovarian cancer
Owner
- Debiopharm International SA, Lausanne, CH
- Debiopharm International SA, Lausanne, CH
- Debiopharm International SA, Lausanne, CH
Prosecution history
- 23 May 2025 — CANCELLED SEC. 8 (6-YR)
- 13 Nov 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 13 Nov 2018 — REGISTERED-PRINCIPAL REGISTER
- 28 Aug 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Aug 2018 — PUBLISHED FOR OPPOSITION
- 08 Aug 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Jul 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 May 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 May 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 May 2018 — ASSIGNED TO LIE
- 21 May 2018 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 Nov 2017 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 Nov 2017 — NON-FINAL ACTION E-MAILED
- 20 Nov 2017 — NON-FINAL ACTION WRITTEN
- 17 Nov 2017 — ASSIGNED TO EXAMINER